Shen W K, Munger T M, Stanton M S, Osborn M J, Hammill S C, Packer D L
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
J Cardiovasc Electrophysiol. 1997 Jun;8(6):627-38. doi: 10.1111/j.1540-8167.1997.tb01825.x.
This study investigated whether fast pathway conduction properties are altered by slow pathway ablation in patients with AV nodal reentrant tachycardia.
Forty consecutive patients who underwent successful ablation of the slow pathway were prospective subjects for the study. Isoproterenol was used to enhance conduction and to differentiate interactive mechanisms. Potential electrotonic interactions were assessed by comparing patients with and those without residual dual AV node physiology after slow pathway ablation. Paired and unpaired t-tests were used when appropriate P < 0.05 was considered statistically significant. In the entire study population, heart rates were not significantly different before and after slow pathway ablation (RR = 770 +/- 114 msec before and 745 +/- 99 msec after, P = 0.07). Anterograde fast pathway conduction properties were unchanged after slow pathway ablation (effective refractory period, 348 +/- 84 msec before and 336 +/- 86 msec after, P = 0.13; shortest 1:1 conduction, 410 +/- 93 msec before and 400 +/- 82 msec after, P = 0.39). Retrograde fast pathway characteristics also were similar before and after ablation. Neither anterograde nor retrograde fast pathway conduction properties during isoproterenol infusion were changed by slow pathway ablation. When the study population was further divided into patients with (n = 13) or without (n = 27) residual dual AV node physiology, no significant change was detected in fast pathway function in either group after slow pathway ablation.
Fast pathway conduction characteristics were not affected by slow pathway ablation. In patients with AV nodal reentrant tachycardia, observations suggest that fast and slow pathways are functionally distinct.
本研究调查了房室结折返性心动过速患者慢径路消融是否会改变快径路传导特性。
连续40例成功进行慢径路消融的患者为该研究的前瞻性研究对象。使用异丙肾上腺素增强传导并区分相互作用机制。通过比较慢径路消融后有或无残余双房室结生理功能的患者来评估潜在的电紧张性相互作用。在适当情况下使用配对和非配对t检验,P<0.05被认为具有统计学意义。在整个研究人群中,慢径路消融前后心率无显著差异(消融前RR=770±114毫秒,消融后745±99毫秒,P=0.07)。慢径路消融后顺行快径路传导特性未改变(有效不应期,消融前348±84毫秒,消融后336±86毫秒,P=0.13;最短1:1传导,消融前410±93毫秒,消融后400±82毫秒,P=0.39)。消融前后逆行快径路特征也相似。慢径路消融未改变异丙肾上腺素输注期间的顺行或逆行快径路传导特性。当将研究人群进一步分为有(n=13)或无(n=27)残余双房室结生理功能的患者时,慢径路消融后两组的快径路功能均未检测到显著变化。
慢径路消融不影响快径路传导特征。在房室结折返性心动过速患者中,观察结果表明快径路和慢径路在功能上是不同的。